Cargando…

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease

Detalles Bibliográficos
Autores principales:	Zhao, Yuhai, Lukiw, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247146/ https://www.ncbi.nlm.nih.gov/pubmed/35783095 http://dx.doi.org/10.3389/fncel.2022.937961

Ejemplares similares

SARS-CoV-2, long COVID, prion disease and neurodegeneration
por: Zhao, Yuhai, et al.
Publicado: (2022)

The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2
por: Xu, Jiali, et al.
Publicado: (2021)

SARS-CoV-2: is there neuroinvasion?
por: McQuaid, Conor, et al.
Publicado: (2021)

microRNA, the Innate-Immune System and SARS-CoV-2
por: Hill, James M., et al.
Publicado: (2022)

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2018)

Gastrointestinal (GI)-Tract Microbiome Derived Neurotoxins and their Potential Contribution to Inflammatory Neurodegeneration in Alzheimer’s Disease (AD)
por: Lukiw, Walter J., et al.
Publicado: (2021)

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide
por: Lukiw, Walter J., et al.
Publicado: (2019)

Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer’s Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures
por: Zhao, Yuhai, et al.
Publicado: (2017)

SARS-CoV-2 Invasion and Pathological Links to Prion Disease
por: Lukiw, Walter J., et al.
Publicado: (2022)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated Aβ42 Peptide Clearance
por: Zhao, Yuhai, et al.
Publicado: (2016)

SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)

Neuroinvasion of SARS-CoV-2 in human and mouse brain
por: Song, Eric, et al.
Publicado: (2020)

Neuroinvasion of SARS-CoV-2 in human and mouse brain
por: Song, Eric, et al.
Publicado: (2021)

microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2015)

Aluminum and its potential contribution to Alzheimer's disease (AD)
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

Gastrointestinal Tract Microbiome-Derived Pro-inflammatory Neurotoxins in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2021)

Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
por: Hill, James M., et al.
Publicado: (2014)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
por: Esposito, Giuseppe, et al.
Publicado: (2020)

SARS-CoV-2 S1 Protein Induces Endolysosome Dysfunction and Neuritic Dystrophy
por: Datta, Gaurav, et al.
Publicado: (2021)

TREM2 signaling, miRNA-34a and the extinction of phagocytosis
por: Zhao, Yuhai, et al.
Publicado: (2013)

Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2019)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients
por: Alipoor, Shamila D., et al.
Publicado: (2021)

Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2014)

The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model
por: Ju, Jiahang, et al.
Publicado: (2022)

Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration
por: Devier, Deidre J., et al.
Publicado: (2015)

Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences
por: Lahiri, Durjoy, et al.
Publicado: (2020)

Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
por: de Melo, Guilherme Dias, et al.
Publicado: (2023)

Genetics of Aggression in Alzheimer’s Disease (AD)
por: Lukiw, Walter J., et al.
Publicado: (2017)

NF-kB (p50/p65)-Mediated Pro-Inflammatory microRNA (miRNA) Signaling in Alzheimer's Disease (AD)
por: Lukiw, Walter J.
Publicado: (2022)

Microbial-generated amyloids and Alzheimer's disease (AD)
por: Hill, James M., et al.
Publicado: (2015)

The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp
por: Liu, Nanyang, et al.
Publicado: (2023)

Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses
por: Chen, Xiaodi
Publicado: (2020)

New Inroads Into Our Understanding of the Tauopathies, Alzheimer's Disease, and the Contribution of Altered Protein Conformation to Human Neurological Disease
por: Lukiw, Walter J.
Publicado: (2022)

Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins
por: Gonçalves, Carlos-Alberto, et al.
Publicado: (2022)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

Editorial: Synaptic Loss and Neurodegeneration
por: Subramanian, Jaichandar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e7bal4ead7pdq8h2sqk3o4ovak